NTRK1 and acute myeloid leukemia: Moreover, an NTRK1 splice variant, TRKA III, and an in-frame deletion mutant (ΔTRKA) were reported in neuroblastoma and acute myeloid leukemia, showing their tumorigenicity [7, 8].